Original Research
Published on 09 May 2022
Serum Metabolomics Benefits Discrimination Kidney Disease Development in Type 2 Diabetes Patients
in Nephrology

- 3,357 views
- 12 citations
Original Research
Published on 09 May 2022
in Nephrology
Review
Published on 06 May 2022
in Nephrology
Review
Published on 06 May 2022
in Nephrology
Review
Published on 06 May 2022
in Nephrology
Editorial
Published on 04 May 2022
in Nephrology
Case Report
Published on 04 May 2022
in Nephrology
Mini Review
Published on 04 May 2022
in Nephrology
Systematic Review
Published on 03 May 2022
in Nephrology
Original Research
Published on 29 Apr 2022
in Nephrology
Original Research
Published on 29 Apr 2022
in Nephrology
Original Research
Published on 29 Apr 2022
in Nephrology
Original Research
Published on 29 Apr 2022
in Nephrology
Original Research
Published on 29 Apr 2022
in Nephrology
Case Report
Published on 28 Apr 2022
in Nephrology
Original Research
Published on 28 Apr 2022
in Nephrology
Systematic Review
Published on 27 Apr 2022
in Nephrology